Optimization of Scalable rAAV Production for Gene Therapy – Utilizing At-Line Amino Acid Measurements for Bioprocess

The REBEL device enabled data-driven bioprocess development for rAAV manufacturing in HEK293 cells by accurately and precisely quantitating amino acids, leading to deeper process understanding. This poster was highlighted at the 2024 ASGCT Conference, ISCT 2024 and ESACT 2024.

email Subscribe to Our Communications Signup to receive new product updates, technical tips and more.